![]() ![]() Survivors may have lasting ramifications and chronic respiratory and cardiovascular issues. Between 10 and 30 percent will die within one month of diagnosis, and one third will have a recurrence within 10 years. Estimates place the number of persons affected as high as 900,000. The National Center for Health Statistics estimates that DVT is an underlying cause of death for up to 100,000 people annually in the U.S. ![]() ![]() PE has been reported to occur in over one third of DVT patients and frequently causes sudden death. 1 A consecutive pulmonary embolism, or PE, can occur when a clot breaks free and travels through the veins and lodges in the lungs. DVT risk is greatest between two and five days after surgery, with a second peak risk period occurring about 10 days after surgery-after the patient has been discharged. Symptoms may include pain, swelling and skin discoloration, or no signs at all. Typically it occurs in the thigh or calf and can develop after any major surgery. By reducing DVT-related expenses and potentially reducing costs for anticoagulant regimes or compression device rental programs, PlasmaFlow helps reduce the total cost of the episode.ĭVT Information DVT Definitions and Statisticsĭeep vein thrombosis (DVT) refers to the development of blood clots, or thrombi, within a deep vein. Lowers Total Costs: Bundled payment of care initiatives are driving single payment for an orthopedic episode within 30-90 days of surgery, including costly DVT readmissions.Improves Patient Experience: PlasmaFlow enables patients to have the prophylaxis they need, in a simple, easy to use device without tubes or hoses.This allows facilities to offer mechanical DVT prophylaxis for the 2-3 weeks patients need it most, without the hassle of renting or servicing equipment. Provides Convenient Home Therapy: As hospital stays continue to shorten, PlasmaFlow provides a portable solution for patients to take home and keep.Provides Possible Alternative to Anticoagulants: PlasmaFlow offers physicians another option to help tailor preventative care to patient risk and provides an alternative for patients contraindicated for anticoagulants.Helps Prevent Onset of Deep Vein Thrombosis (DVT): PlasmaFlow helps prevent DVT, a leading factor for hospital readmission following major orthopedic surgery. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |